1,114 filings
Page 3 of 56
PX14A6G
0pdm9rzkd2l9w oozuk
12 Apr 23
Letter to shareholders
9:04am
DEFA14A
w3i9358hz
10 Apr 23
Additional proxy soliciting materials
10:43am
DEFA14A
224cc
10 Apr 23
Additional proxy soliciting materials
10:40am
PX14A6G
4tt8z n3d
4 Apr 23
Letter to shareholders
11:46am
DEFA14A
z6b5ii qpmos
30 Mar 23
Additional proxy soliciting materials
5:28pm
PX14A6G
l0vtn0xf f19y
22 Mar 23
Letter to shareholders
12:34pm
ARS
8xkj 8gocvb0el4d
16 Mar 23
Annual report to shareholders
6:43pm
DEFA14A
j9tongje4jn8
16 Mar 23
Additional proxy soliciting materials
9:25am
8-K
droz3oismgzvgn
13 Mar 23
Pfizer to acquire Seagen for $229 per Seagen share in cash, for a total enterprise value of approximately $43 billion
8:29am
S-8
4svradw
24 Feb 23
Registration of securities for employees
8:02pm
8-K
slvyggb6
21 Feb 23
Other Events
4:17pm
8-K
tnk 99k22wlhxwm
31 Jan 23
Pfizer Reports Record Full-year 2022 Results and Provides Full-year 2023 Financial Guidance
8:11am
8-K
qkrjf9u 0ozouo3q
13 Dec 22
Amendments to Articles of Incorporation or Bylaws
4:19pm
8-K
tarxvovkjjyxume
1 Nov 22
Pfizer Reports Strong Third-quarter 2022 Results and Raises 2022 Outlook
8:11am
8-K
1ucnu0yv70e58b7 yb
28 Jul 22
Pfizer Reports Second-quarter 2022 Results
8:09am